NORTHWEST BIOTHERAPEUTICS INC (NWBO)

Every figure this model derived for NWBO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 1,434,000 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 595,000 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 2,574,000 AssetsCurrent 2026-06-30
current liabilities 73,352,000 LiabilitiesCurrent 2026-06-30
equity -45,174,000 StockholdersEquity 2026-06-30
interest expense 9,422,000 InterestExpenseNonoperating 2026-06-30
ocf -48,335,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 2,173,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 927,000 AllocatedShareBasedCompensationExpense 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up NWBO on one particular measure came for.

RatioValue
cash operating margin-2148.09
current ratio0.04
current ratio reported0.04
dilution pct17.27
fcf margin-2290.34
growth cv5.47
interest cover-5.34
operating margin-2316.11
revenue growth98.63
revenue growth per share69.37
roic-640.88
rule of 40-2217.48
sbc pct revenue42.66

What to be careful about

What this model itself distrusts about NWBO's figures. Written by the derivation as it ran, not added afterwards.